These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Exploring the functions of polymers in adenovirus-mediated gene delivery: Evading immune response and redirecting tropism. Sun Y; Lv X; Ding P; Wang L; Sun Y; Li S; Zhang H; Gao Z Acta Biomater; 2019 Oct; 97():93-104. PubMed ID: 31386928 [TBL] [Abstract][Full Text] [Related]
6. Integrin-Targeting Strategies for Adenovirus Gene Therapy. Nemerow GR Viruses; 2024 May; 16(5):. PubMed ID: 38793651 [TBL] [Abstract][Full Text] [Related]
7. Adenovirus receptors: implications for targeting of viral vectors. Arnberg N Trends Pharmacol Sci; 2012 Aug; 33(8):442-8. PubMed ID: 22621975 [TBL] [Abstract][Full Text] [Related]
8. Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy. Yoon AR; Hong J; Kim SW; Yun CO Expert Opin Drug Deliv; 2016 Jun; 13(6):843-58. PubMed ID: 26967319 [TBL] [Abstract][Full Text] [Related]
9. Transductional targeting of adenovirus vectors for gene therapy. Glasgow JN; Everts M; Curiel DT Cancer Gene Ther; 2006 Sep; 13(9):830-44. PubMed ID: 16439993 [TBL] [Abstract][Full Text] [Related]
11. Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models. Van Houdt WJ; Wu H; Glasgow JN; Lamfers ML; Dirven CM; Gillespie GY; Curiel DT; Haviv YS Neuro Oncol; 2007 Jul; 9(3):280-90. PubMed ID: 17522331 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus vectors composed of subgroup B adenoviruses. Sakurai F; Kawabata K; Mizuguchi H Curr Gene Ther; 2007 Aug; 7(4):229-38. PubMed ID: 17969556 [TBL] [Abstract][Full Text] [Related]
13. Advances towards targetable adenovirus vectors for gene therapy. Einfeld DA; Roelvink PW Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045 [TBL] [Abstract][Full Text] [Related]
14. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting. Jönsson F; Hagedorn C; Kreppel F J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881 [TBL] [Abstract][Full Text] [Related]
16. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. Shayakhmetov DM; Eberly AM; Li ZY; Lieber A J Virol; 2005 Jan; 79(2):1053-61. PubMed ID: 15613334 [TBL] [Abstract][Full Text] [Related]
17. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740 [TBL] [Abstract][Full Text] [Related]
18. Transductional targeting with recombinant adenovirus vectors. Legrand V; Leissner P; Winter A; Mehtali M; Lusky M Curr Gene Ther; 2002 Sep; 2(3):323-39. PubMed ID: 12189719 [TBL] [Abstract][Full Text] [Related]
19. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. Dmitriev I; Krasnykh V; Miller CR; Wang M; Kashentseva E; Mikheeva G; Belousova N; Curiel DT J Virol; 1998 Dec; 72(12):9706-13. PubMed ID: 9811704 [TBL] [Abstract][Full Text] [Related]
20. The influence of adenovirus fiber structure and function on vector development for gene therapy. Nicklin SA; Wu E; Nemerow GR; Baker AH Mol Ther; 2005 Sep; 12(3):384-93. PubMed ID: 15993650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]